NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

ALGN | NASDAQ

$150.72 $0.00 | 0.00%

Next Earnings: Sep 10, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 12.7x
Payout Ratio (TTM):
52-Week Range: $122.00 - $200.44

* Forward PE is based on street estimates.

10 Year ALGN Performance Metrics:

Total Return (with DRIP): 61.9% (4.93% CAGR)
Total Return (no DRIP): 61.9% (4.93% CAGR)
Share Price: 64.2% (5.08% CAGR)
Yield on Cost (with DRIP):
Total Invested: $10,000
Total Value (with DRIP): $16,186
Total Return $ (with DRIP): $6,186
ALGN Total Return
1Y 2Y 5Y 10Y All
ALGN Price Chart
1Y 2Y 5Y 10Y All
DRIPCalc.com
ALGN Price

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)

ALGN Earnings, Revenue, Cash & Debt, Shares Outstanding:

ALGN - Revenue
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - Earnings Per Share (EPS)
ALGN EPS CAGR:1Y: -12.21%2Y: 8.61%5Y: -9.66%10Y: 9.31%
ALGN - Net Income
🔒 Unlock
ALGN Net Income CAGR:1Y: -13.09%2Y: 5.90%5Y: -11.52%10Y: 8.00%
ALGN - EBITDA
🔒 Unlock
ALGN EBITDA CAGR:1Y: 26.85%2Y: 12.56%5Y: 0.20%10Y: 14.48%
ALGN - Free Cash Flow
🔒 Unlock
ALGN Free Cash Flow CAGR:1Y: 2.05%2Y: 21.52%5Y: -4.06%10Y: 10.60%
ALGN - Free Cash Flow / Share
🔒 Unlock
ALGN Free Cash Flow / Share CAGR:1Y: 47.46%2Y: 48.69%5Y: 5.04%10Y: 15.87%
ALGN - Operating Income
🔒 Unlock
ALGN Operating Income CAGR:1Y: 18.21%2Y: 14.48%5Y: -6.44%10Y: 11.46%
ALGN - Gross Profit
🔒 Unlock
ALGN Gross Profit CAGR:1Y: 6.96%2Y: 2.38%5Y: -0.03%10Y: 13.95%
ALGN - Shares Outstanding
🔒 Unlock
ALGN Shares Outstanding CAGR:1Y: -1.48%2Y: -2.49%5Y: -2.13%10Y: -1.27%
ALGN - Share Buybacks
🔒 Unlock
ALGN Share Buybacks CAGR:1Y: -30.31%2Y: -33.20%5Y: 0.00%10Y: 6.70%
ALGN - Stock-Based Comp
🔒 Unlock
ALGN Stock-Based Comp CAGR:1Y: 0.00%2Y: -1.57%5Y: 9.57%10Y: 12.77%
ALGN - Expenses
🔒 Unlock
ALGN Expenses CAGR:1Y: 21.73%2Y: -24.11%5Y: -24.35%10Y: 5.05%
ALGN - Revenue vs Net Income
🔒 Unlock
ALGN - EPS vs FCF / Share
🔒 Unlock
ALGN - EPS vs PE Ratio
🔒 Unlock
ALGN - FCF vs FCF / Share
🔒 Unlock
ALGN - FCF vs Stock Based Comp
🔒 Unlock
ALGN - Cash & Debt
🔒 Unlock
ALGN - Revenue by Segment
🔒 Unlock
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - Revenue by Region
🔒 Unlock
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ALGN - REVENUE: Actual + Estimates
🔒 Unlock
ALGN Actual Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - EPS: Actual + Estimates
🔒 Unlock
ALGN Actual EPS CAGR:1Y: -12.21%2Y: 8.61%5Y: -9.66%10Y: 9.31%
ALGN - NET INCOME: Actual + Estimates
🔒 Unlock
ALGN Actual Net Income CAGR:1Y: -13.09%2Y: 5.90%5Y: -11.52%10Y: 8.00%
ALGN - EBITDA: Actual + Estimates
🔒 Unlock
ALGN Actual EBITDA CAGR:1Y: 26.85%2Y: 12.56%5Y: 0.20%10Y: 14.48%

Ratios, Profit Margins & Return on Capital:

ALGN - Net Profit Margin
🔒 Unlock
ALGN Net Profit Margin CAGR:1Y: -16.73%2Y: 4.48%5Y: -12.30%10Y: -5.79%
ALGN - Gross Profit Margin
🔒 Unlock
ALGN Gross Profit Margin CAGR:1Y: -6.86%2Y: -3.71%5Y: -2.79%10Y: -1.55%
ALGN - Price to Earnings
🔒 Unlock
ALGN - Price To Sales Ratio
🔒 Unlock
ALGN - Return on Capital Employed
🔒 Unlock
ALGN - Return on Invested Capital
🔒 Unlock

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ALGN

Based on past 10-year performance, here are ALGN growth metrics:

Share price CAGR of +5.08%
Dividend CAGR of +0%

Using ALGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

ALGN (DRIP)ALGN - No DRIP
Current Price$150.72$150.72
Start Shares66.3566.35
Start Value$10,000$10,000
  
After 10 years:
Final Share Count66.3566.35
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$150.72$150.72
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - ALGN

NOTE: Above numbers are our estimate based on ALGN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)

Company Info

Align Technology, Inc. (ALGN) had its IPO on 2001-01-30, and is trader on NASDAQ stock exchange.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

ALGN website: https://www.aligntech.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)